Because prandial insulin is often dosed proportionally to carbohydrate intake in type 1 diabetes, the RCD offers a means to decrease the total daily dose of insulin (TDDinsulin), potentially mitigating insulin resistance and endothelial dysfunction associated with iatrogenic peripheral hyperinsulinemia. This evidence concerns the gene INS and type 1 diabetes mellitus.